Strategic leadership Recent executive changes indicate a potential refresh in strategic priorities and vendor relationships. Engage with the new CEO to align on flagship forensic DNA workflow enhancements, partnerships, and technology investments.

Expansion opportunities Expansion of facilities to Manila and the broader Asia-Pacific region creates demand for regional demonstration, training, and local support. Offer scalable on-site and remote training, localized service agreements, and region-specific data workflows.

End-to-end solutions QIAGEN HID provides comprehensive sample-to-insights capabilities across DNA workflow, automation, and sequencing analysis. Position integrated hardware, consumables, and software licenses as a unified value proposition to laboratories seeking efficiency and standardization.

Public market signals Market activity and revenue indicators show growth trajectories and investor interest in Qiagen. Leverage this momentum to propose expansion of service contracts, upgrade cycles for sequencing systems, and bundled offerings that align with capital expenditure plans.

Sustainability & compliance Forensic labs increasingly prioritize validated, compliant workflows and data security. Highlight QA/validation services, regulatory-compliant software, and secure data management to reduce risk and support accelerated adoption of new panels and HIV testing capabilities.